Open Access Open Access  Restricted Access Subscription or Fee Access

Silver nano particles ameliorate learning and spatial memory of male wistar rats by prevention of amyloid fibril-induced neurotoxicity

H. Ramshini, A.-S. Moghaddasi, L.-S. Aldaghi, N. Mollania, A. Ebrahim-Habibi


Alzheimer’s disease (AD) is a chronic degenerative disease characterized by the presence of amyloid plaques and neurofibrillary tangles (NFTs), which results into memory and learning impairments. In the present study, we showed that the aggregates formed by a protein that has no link with Alzheimer’s disease, namely the hen egg white lysozyme (HEWL), were cytotoxic and decreased spatial learning and memory in rats. The effect of Ag-nano particles (Ag-NPs) was investigated on disruption of amyloid aggregation and preservation of cognitive behavior of rats. Twenty-four male Wistar rats were divided into 4 groups including a control group, and injected with either scopolamine, lysozyme or aggregates pre-incubated with Ag-NPs. Rats’ behavior was monitored using Morris water maze (MWM) twenty days after injections. HEWL aggregation in the presence and absence of the Ag-NPs was assayed by Thioflavin T binding, atomic force microscopy and cell-based cytotoxicity assay. Ag-NPs were capable to directly disrupt HEWL oligomerization and the resulting aggregates were non-toxic. We also showed that rats of the Ag-NPs group found MWM test platform in less time and with less distance traveled, in comparison with lysozyme group. Ag-NPs also increased the percentage of time elapsed and the distance swum in the target quadrant in the rat model of AD, in probe test. These observations suggest that Ag-NPs improved spatial learning and memory by inhibiting amyloid fibril-induced neurotoxicity. Furthermore, we suggest using model proteins as a valid tool to investigate the pathogenesis of Alzheimer’s disease.


Amyloid aggregation; Silver nano particles; Cytotoxicity; Water maze; Spatial memory

Full Text:



Amiri H., Saeidi K., Borhani P., Manafirad A., Ghavami M., Zerbi V. Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents, ACS Chem. Neurosci. 4: 1417-29, 2013.

Baglioni S., Casamenti F., Bucciantini M., Luheshi L.M., Taddei N., Chiti F., Dobson C.M., Stefani M. Prefibrillar amyloid aggregates could be generic toxins in higher organisms, J. Neurosci. 26: 8160-7, 2006.

Barghorn S., Nimmrich V., Striebinger A., Krantz C., Keller P., Janson B., Bahr M., Schmidt M., Bitner R.S., Harlan J., Barlow E., Ebert U., Hillen H. Globular amyloid beta-peptide oligomer- a homogenous and stable neuropathological protein in Alzheimer’s disease. J. Neurochem. 95: 834-847, 2005.

Benilova E., Karran B.D. Strooper, The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat. Neurosci. 15: 349–357, 2012.

Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Rev. 21: 285–300, 1995.

Brambilla D., Verpillot R., Le Droumaguet B., Nicolas J., Taverna M., Kóňa J., Lettiero B., Hashemi S.H., De Kimpe L., Canovi M., Gobbi M., Nicolas V., Scheper W., Moghimi SM., Tvaroška I., Couvreur P., Andrieux K. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease. ACS Nano. 6: 5897-908, 2012.

Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507–511, 2002.

Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U.S.A. 96: 3590–3594, 1999.

Clark R.E., Broadbent N.J., Squire L.R. The hippocampus and spatial memory: findings with a novel modification of the water maze. J. Neurosci. 27: 6647-54, 2007.

Fezoui Y., Hartley D.M., Walsh D.M., Selkoe D.J., Osterhout J.J., Teplow D.B. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat. Struct. Biol. 7: 1095-9, 2000.

Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 3: 519-526, 1989.

Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell Bio. 8: 101–112, 2007.

Ibi D., Takuma K., Koike H., Mizoguchi H., Tsuritani K., Kuwahara Y., Kamei H., Nagai T., Yoneda Y., Nabeshima T., Yamada K. Social isolation rearing induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. J. Neurochem. 105: 921-32, 2008.

Kim Y., Park J.H., Lee H., Nam J.M. How do the size, charge and shape of nanoparticles affect amyloid β aggregation on brain lipid bilayer? Sci. Rep. 6: 19548, 2016.

Ladiwala A.A., Dordick J.S., Tessier P.M. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J. Biol. Chem. 286: 3209–3218, 2011.

Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M., Iwatsubo T., Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153: 1998, 1365-1370.

Li Q., Zhao H.F., Zhang Z.F., Liu Z.G., Pei X.R., Wang J.B., Li Y. Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticityrelated proteins in the hippocampus. Neuroscience 163: 741–9, 2009.

Loo S.L., Fane A.G., Lim T.T., Krantz W.B., Liang Y.N., Liu X., Hu X. Superabsorbent cryogels decorated with silver nanoparticles as a novel water technology for point-of-use disinfection. Environ. Sci. Technol. 47: 9363–9371, 2013.

Mahmoudi M., Quinlan-Pluck F., Monopoli M.P., Sheibani S., Vali H., Dawson K.A., Lynch I. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid beta protein fibrillation in solution. ACS Chem. Neurosci. 4: 475−485, 2013.

Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55–63, 1983.

Nilsson M. R. Techniques to study amyloid fibril formation in vitro. Methods 34: 151-160, 2004.

Pavlova M.K., Shea S.A., Bromfield E.B. Day/night patterns of focal seizures. Epilepsy Behav. 5: 44–9, 2004.

Poling A., Morgan-Paisley K., Panos J.J., Kim E.M., O'Hare E., Cleary J.P., Lesné S., Ashe K.H., Porritt M., Baker L.E. Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behav. Brain. Res. 193: 230-234, 2008.

Ramshini H., mohammad-zadeh M., Ebrahim-Habibi A. Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor. Int. J. Biol. Macromol. 78: 396-404, 2015.

Salata O.V. Applications of nanoparticles in biology and medicine, J. Nanobiotechnology. 2: 3, 2004.

Salomone S., Caraci F., Leggio G.M., Fedotova J., Drago F. New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease modifying drugs. Br. J. Clin. Pharmacol. 73: 504–517, 2012.

Schwarze-Eicker K, Keyvani K., Görtz N., Westaway D., Sachser N., Paulus W. Prion protein (PrPc) promotes b-amyloid plaque formation, Neurobiol. Aging. 26: 1177-1182, 2005.

Selkoe D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain. Res. 192: 106-113, 2008.

Sharma V.K., Yngard R.A., Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv, Colloid Sur. Interface 145: 83-96, 2009.

Sirangelo I., Malmo C., Iannuzzi C., Mezzogiorno A., Bianco M.R., Papa M., Irace G. Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F. J. Biol. Chem. 279: 13183–13189, 2004.

Skaat H., Belfort G., Margel S. Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation, Nanotechnology. 20: 225106, 2009.

Skaat H., Margel S. Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic field. Biochem. Biophys. Res. Commun. 386: 645−649, 2009.

Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. (Berl). 81: 678-99, 2003.

Swaminathan R., Ravi V.K., Kumar S., Kumar M.V., Chandra N. Lysozyme: a model protein for amyloid research. Adv. Protein Chem. Struct. Biol. 84: 63-111, 2011.

Tatini F., Pugliese A.M., Traini C., Niccoli S., Maraula G., Ed-Dami T., Mannini B., Scartabelli T., Pedata F., Casamenti F., Chiti F. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N. Neurobiol. Aging 34: 2100-9, 2013.

Tang Z., Zhang Z., Wang Y., Glotzer S.C., Kotov N.A. Self-assembly of CdTe nanocrystals into free-floating sheets. Science 314: 274–278, 2006.

Terry R.D. Where in the brain does Alzheimer’s disease begin? Ann. Neurol. 47: 421. 2000.

Wilcock D.M., Gordon M.N., Morgan D. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain, Nat. Protocols. 1: 1591-95, 2006.

Xu M, Shashilov V.A., Ermolenkov V.V., Fredriksen L., Zagorevski D., Lednev I.K. The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition. Protein Sci. 16: 815-832, 2007.

Yehuda S., Mostofsky D.I. Circadian effects of beta-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures. Peptides 14: 203–5, 1993.

Zhang W., Chen Z., Liu H., Zhang L., Gao P., Li D. Biosynthesis and structural characteristics of selenium nanoparticles by Pseudomonas alcaliphila, Colloids Surf. B Biointerfaces 88: 196-201, 2011.